1. Home
  2. QRVO vs BIO Comparison

QRVO vs BIO Comparison

Compare QRVO & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Qorvo Inc.

QRVO

Qorvo Inc.

HOLD

Current Price

$86.90

Market Cap

8.1B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$321.91

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
QRVO
BIO
Founded
1957
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
8.2B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
QRVO
BIO
Price
$86.90
$321.91
Analyst Decision
Hold
Strong Buy
Analyst Count
14
4
Target Price
$98.23
$358.50
AVG Volume (30 Days)
882.5K
146.2K
Earning Date
01-27-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.30
N/A
Revenue
$3,663,072,000.00
$2,557,500,000.00
Revenue This Year
$3.36
$1.62
Revenue Next Year
$2.39
$2.26
P/E Ratio
$37.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$49.46
$211.43
52 Week High
$106.30
$373.69

Technical Indicators

Market Signals
Indicator
QRVO
BIO
Relative Strength Index (RSI) 51.48 63.13
Support Level $84.50 $300.26
Resistance Level $87.50 $305.62
Average True Range (ATR) 1.56 7.83
MACD 0.00 1.32
Stochastic Oscillator 52.69 97.97

Price Performance

Historical Comparison
QRVO
BIO

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: